RIQAS TDM EQA Program
RIQAS (Randox International Quality Assessment Scheme) is the world’s largest global EQA scheme serving over 24,000 laboratory participants in more than 105 countries worldwide.
The RIQAS Therapeutic Drugs programme covers a wide range of 18 drugs. Weighed in values are reported for each parameter.
RIQAS TDM EQA Program Features:
- Accredited to ISO/IEC 17043:2010
- 100% human serum samples
- Bi-weekly sampling
- User friendly reports available within 72 hours
- End-of cycle reports and certificates of participation provided
- Register up to five instruments at no extra cost
Full List of Parameters Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digoxin, Ethosuximide, Genatmicin, Lithium, Methotrexate, Paracetamol, Phenobarbital, Phenytoin, Primidone, Salicylic Acid, Theophylline, Tobramycin, Valproic Acid, Vancomycin